Log in to search using one of your social media accounts:

 

Janssen receives two u.s. fda approvals for simponi aria ® (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis
SIMPONI ARIA ® is the Only Fully-Human Anti-TNF-alpha Infused Therapy Now Approved for Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis (Source: Johnson and Johnson)
Source: Johnson and Johnson - October 21, 2017 Category: Pharmaceuticals Source Type: news

Tofacitinib Shows Promise in Psoriatic Arthritis Tofacitinib Shows Promise in Psoriatic Arthritis
Tofacitinib is better than placebo for psoriatic arthritis that has responded poorly to treatment with conventional disease-modifying antirheumatic drugs and tumor necrosis factor inhibitors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 18, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Magnetic Resonance Imaging in Psoriatic Arthritis Magnetic Resonance Imaging in Psoriatic Arthritis
A new study explores the important role axial and peripheral MRI scans can play in the evaluation and management of patients with psoriatic arthritis.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

What Are the Different Types of Psoriatic Arthritis?
Title: What Are the Different Types of Psoriatic Arthritis?Category: Doctor's& Expert's views on SymptomsCreated: 10/2/2017 12:00:00 AMLast Editorial Review: 10/2/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - October 2, 2017 Category: Rheumatology Source Type: news

Sonographic Enthesitis and Radiographic Damage in PsA Sonographic Enthesitis and Radiographic Damage in PsA
Is the severity of sonographic enthesitis a predictor of joint damage in psoriatic arthritis patients?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 27, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Education, Screening for Psoriatic Arthritis Key in Psoriasis Education, Screening for Psoriatic Arthritis Key in Psoriasis
A new study compares screening methods for psoriatic arthritis, underscoring the importance of incorporating patient education and screening of PsA into clinical assessment of patients with psoriasis.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 31, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Secukinumab for Psoriasis and Psoriatic Arthritis Secukinumab for Psoriasis and Psoriatic Arthritis
This article reviews phase II and phase III clinical trials for secukinumab, an IL-17A inhibitor which presents a promising new treatment approach for refractory psoriasis and psoriatic arthritis.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 15, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

FDA Advisory Committee votes in favor of XELJANZ ® (tofacitinib citrate) for the treatment of active psoriatic arthritis
Pfizer Inc. announced that the United States Food and Drug Administration's (FDA) Arthritis Advisory Committee (AAC) voted 10 to 1 to recommend approval of the proposed dose of tofacitinib for the treatment of adult patients with active psoriatic arthritis (PsA). Pfizer submitted supplemental new drug applications (sNDAs) for XELJANZ® 5 mg twice daily (BID) and XELJANZ® XR extended release 11 mg once daily (QD) for this pending indication. (Source: World Pharma News)
Source: World Pharma News - August 4, 2017 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

FDA approves Bristol-Myers Squibb ’s Orencia for active psoriatic arthritis
The US Food and Drug Administration (FDA) has approved Bristol-Myers Squibb ’s Orencia for the treatment of adult patients with active psoriatic arthritis (PsA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 9, 2017 Category: Pharmaceuticals Source Type: news

Bristol-Myers Squibb ’s Orencia (abatacept) Receives FDA Approval for Treatment of Active Psoriatic Arthritis in Adults
PRINCETON, N.J.--(BUSINESS WIRE) July 6, 2017 --Bristol-Myers Squibb Company (NYSE:BMY) announced today the U.S. Food and Drug Administration (FDA) has approved Orencia for the treatment of adults with active Psoriatic Arthritis (PsA)1, a chronic2,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 6, 2017 Category: Drugs & Pharmacology Source Type: news

Psoriatic Arthritis Often Remits During Pregnancy (CME/CE)
(MedPage Today) -- Arthritis trends favorably; psoriasis improves or remains stable (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - July 5, 2017 Category: Dermatology Source Type: news

Novartis gets European OK for biosimilar of Amgen's Enbrel
ZURICH (Reuters) - Novartis's generics unit Sandoz said the European Commission approved Erelzi, its biosimilar to Amgen's Enbrel, to treat inflammatory diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis. (Source: Reuters: Health)
Source: Reuters: Health - June 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Targeting IL-23 a Hit in Psoriatic Arthritis (CME/CE)
(MedPage Today) -- Multiple disease domains showed significant improvement (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - June 19, 2017 Category: General Medicine Source Type: news

EULAR 2017: Lilly's Taltz(R) (ixekizumab) Demonstrated No Progression or Minimal Progression of Radiographic Disease in Patients with Psoriatic Arthritis Through 52 Weeks
INDIANAPOLIS, June 16, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that the majority of patients with active psoriatic arthritis (PsA) treated with Taltz® (ixekizumab) exhibited either no progres... Biopharmaceuticals Eli Lilly, Taltz, ixekizumab, psoriatic arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2017 Category: Pharmaceuticals Source Type: news

New effective treatments for psoriatic arthritis patients
(European League Against Rheumatism) The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference revealed promising data supporting two new drug classes for the treatment of psoriatic arthritis (PsA). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2017 Category: International Medicine & Public Health Source Type: news

New Phase 3 Data Show Anti-TNF Alpha SIMPONI ARIA ® (golimumab) Significantly Improved Arthritis And Skin Manifestations In Patients With Active Psoriatic Arthritis
Treatment with SIMPONI ARIA ® Showed Significant Inhibition in the Progression of Structural Damage (Source: Johnson and Johnson)
Source: Johnson and Johnson - June 14, 2017 Category: Pharmaceuticals Source Type: news

Ixekizumab Eases Psoriatic Arthritis When TNF Inhibitor Fails Ixekizumab Eases Psoriatic Arthritis When TNF Inhibitor Fails
The selective interleukin-17A inhibitor ixekizumab improved signs and symptoms of active psoriatic arthritis (PsA) in patients who had failed prior biologic therapy in the phase 3 SPIRIT-P2 trial.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 2, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

Identifying Preclinical Psoriatic Arthritis in Hope of Prevention Identifying Preclinical Psoriatic Arthritis in Hope of Prevention
Dr Kevin Deane explains how this new research may provide a window of opportunity for preventing psoriatic arthritis.Medscape Rheumatology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 31, 2017 Category: Pathology Tags: Rheumatology Viewpoint Source Type: news

Arthritis news: Drug could treat condition linked to psoriasis
PSORIATIC arthritis is linked to the skin condition psoriasis and is often painful, but a new drug could help significantly relieve symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - May 30, 2017 Category: Consumer Health News Source Type: news

Promising Results for Drug for Psoriatic Arthritis
Psoriatic arthritis causes painful joint swelling, but new medication Taltz might help (Source: WebMD Health)
Source: WebMD Health - May 26, 2017 Category: Consumer Health News Source Type: news

Promising Results for Drug to Fight Arthritis Linked to Psoriasis
Psoriatic arthritis causes painful joint swelling, but new medication Taltz might help Source: HealthDay Related MedlinePlus Pages: Medicines, Psoriatic Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 26, 2017 Category: Consumer Health News Source Type: news

Promising Results for Ixekizumab Against Psoriatic Arthritis
FRIDAY, May 26, 2017 -- A new drug might help ease the pain and disability of a form of arthritis often linked to psoriasis. According to Stanford University researchers, psoriatic arthritis is an inflammatory joint disorder tied to an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 26, 2017 Category: General Medicine Source Type: news

CME Outfitters Releases Preliminary Outcomes Findings from Psoriatic...
CMEO preliminary results show symposium on psoriatic arthritis featuring patient voice improved knowledge, behavior, and confidence among clinicians(PRWeb May 26, 2017)Read the full story at http://www.prweb.com/releases/2017/05/prweb14373069.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 26, 2017 Category: Pharmaceuticals Source Type: news

Denmark Sees Trend of Rising Psoriatic Arthritis (CME/CE)
(MedPage Today) -- One possible reason: increased attention from patients and docs (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - May 18, 2017 Category: Rheumatology Source Type: news

Minimal Disease Activity and Impact of Disease in PsA Minimal Disease Activity and Impact of Disease in PsA
What is the association between minimal disease activity and the impact of psoriatic arthritis?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Abatacept Helps Joints in Psoriatic Arthritis (CME/CE)
(MedPage Today) -- Benefits were less for skin manifestations (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 7, 2017 Category: Dermatology Source Type: news

Medical News Today: Diet tips for psoriatic arthritis: Foods to eat and avoid
In this article, learn about the foods to eat for people with psoriatic arthritis. Also find how to maintain a healthy gut including the use of probiotics. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 18, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Psoriatic arthritis and fatigue: Treatment, coping, and management
People with psoriatic arthritis may experience fatigue due to inflammation and chronic pain. In this article, learn about how to manage this tiredness. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Ten natural treatments for psoriatic arthritis
In this article, learn about ten natural remedies for psoriatic arthritis, what alternative therapies may be recommended, and the best diet for PsA. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

I’m 33, But My Autoimmune Disease Makes My Body Feel Like I’m 70
As told to Carina Storrs Jennifer Pellegrin, 33, found out she had psoriatic arthritis at a doctor’s visit for an unrelated procedure. At first, she did not think much of the diagnosis or fully understand how it would change her life. But seeing family members cope with the disease opened her eyes to its devastating effects. Now, she finds strength by helping others and credits the autoimmune disease for helping her become the person she is today. At first, being diagnosed with psoriatic arthritis didn’t seem so bad. But that just shows how little I knew about the disease back then. My primary care doctor decid...
Source: Healthy Living - The Huffington Post - April 11, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Psoriatic arthritis: Pictures of symptoms and progression
In this article, we look at the different stages and symptoms of psoriatic arthritis, a chronic condition which may worsen over time. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 11, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Causes of psoriatic arthritis: Triggers and risk factors
Learn about the common triggers for symptoms of psoriatic arthritis, including stress, smoking, and cold weather. What role does family history play? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 9, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Prognosis of psoriatic arthritis: Progression and outlook
In this article, learn how psoriatic arthritis may progress, the quality of life to be expected, and what treatment options are available. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 9, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Psoriatic arthritis radiology: Imaging tests for diagnosis
What is psoriatic arthritis and what types of radiology may be used to make a diagnosis? What other tests may be available and who should get checked? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Galapagos starts dosing in EQUATOR trial of filgotinib to treat psoriatic arthritis
Biotechnology firm Galapagos has started dosing patients in its Phase II EQUATOR clinical trial of filgotinib for the treatment of moderately to severely active psoriatic arthritis. (Source: Drug Development Technology)
Source: Drug Development Technology - April 5, 2017 Category: Pharmaceuticals Source Type: news

Medical News Today: Psoriatic arthritis flare-ups: Triggers, symptoms, and treatment
In this article, we take a close look at a variety of triggers for psoriatic arthritis flare-ups, as well as what can be done to manage them. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 5, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Psoriatic arthritis: Tests and diagnosis
Learn about psoriatic arthritis, the patterns of psoriatic arthritis, how it is diagnosed, what happens after diagnosis, and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 5, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

European Commission Approves AMGEVITA ™ (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
First Biosimilar Adalimumab Approved in the European Union THOUSAND OAKS, Calif., March 23, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted marketing authorization for AMGEVITA™ (biosimilar adalimumab1) in all available indications. AMGEVITA is authorized for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis; psoriatic arthritis; severe active ankylosing spondylitis (AS); severe axial spondyloarthritis without radiographic evidence of AS; moderate-to-severe chronic plaque psoriasis; moderate-to-s...
Source: Amgen News Release - March 23, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Study Examines Characteristics of Psoriatic Spondyloarthritis in Psoriatic Arthritis With Ankylosing Spondylitis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - March 18, 2017 Category: Orthopaedics Tags: CME Article Source Type: news

Transforming MSK care and patient outcomes
Our challenge is to deliver improved care, says Prof Anthony Woolf, chairman of the Arthritis and Musculoskeletal Alliance Related items fromOnMedica Depression raises risk of developing psoriatic arthritis Taking the sting out of osteoarthritis Opioid or muscle relaxant no extra benefit for back pain Physios should be first point of contact for musculoskeletal problems (Source: OnMedica Views)
Source: OnMedica Views - March 13, 2017 Category: Primary Care Source Type: news

Your NEJM Group Today: Psoriatic Arthritis Review / CV Effects of Caffeine / Florida Family Practice Opportunity (FREE)
By the Editors Check out today's selections from NEJM Group:NEJM Clinical Practice Center: Review: Psoriatic arthritis occurs in up to 30% of … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 12, 2017 Category: Primary Care Source Type: news

RA Drug Active in Psoriatic Arthritis
(MedPage Today) -- Multiple endpoints improved with tofacitinib (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 8, 2017 Category: Dermatology Source Type: news

Can Depression Up Odds for Psoriatic Arthritis?
Mood disorder may increase inflammation throughout the body, researcher says (Source: WebMD Health)
Source: WebMD Health - February 24, 2017 Category: Consumer Health News Source Type: news

Can Depression Up Odds for Arthritis Linked to Psoriasis?
Mood disorder may increase inflammation throughout the body, researcher saysSource: HealthDay Related MedlinePlus Pages: Depression, Psoriasis, Psoriatic Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 24, 2017 Category: Consumer Health News Source Type: news

Can Depression Up Odds for Arthritis Linked to Psoriasis?
FRIDAY, Feb. 24, 2017 -- Depression in people with the chronic inflammatory skin disease psoriasis increases the risk of getting the joint condition known as psoriatic arthritis by about 37 percent, new research indicates. The finding raises... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 24, 2017 Category: Journals (General) Source Type: news

Depression raises risk of developing psoriatic arthritis
Psoriasis patients over a third more likely to develop psoriatic arthritis if depressed Related items fromOnMedica Gene breakthrough confirms existence of psoriatic arthritis New research reveals psychological impact of psoriasis Major depression common in people with psoriasis Psoriasis photo library (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 23, 2017 Category: UK Health Source Type: news

The risk of depression, suicidal ideation, and suicide attempt in patients with psoriasis, psoriatic arthritis, or ankylosing spondylitis - Wu JJ, Penfold RB, Primatesta P, Fox TK, Stewart C, Reddy SP, Egeberg A, Liu J, Simon G.
BACKGROUND: Sparse information is available concerning mental health issues in psoriasis, psoriatic arthritis (PsA), and ankylosing spondylitis (AS) patients. OBJECTIVE: To estimate risk of depression, suicidal ideation, and suicide attempt in pati... (Source: SafetyLit)
Source: SafetyLit - February 23, 2017 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news

Depression puts psoriasis patients at significantly greater risk of psoriatic arthritis
(Elsevier Health Sciences) Psoriasis is a lifelong disease that is associated with significant cosmetic and physical disability and puts patients at increased risk for many major medical disorders. A multidisciplinary team of researchers at the University of Calgary, Canada, have found that psoriasis patients who developed depression were at a 37 percent greater risk of subsequently developing psoriatic arthritis, compared with psoriasis patients who did not develop depression. Their findings are published in the Journal of Investigative Dermatology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 22, 2017 Category: Global & Universal Source Type: news